HHLR Advisors’s CureVac CVAC Stock Holding History

HHLR Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-51,199	Closed	-$4.15M	–	95
2020 Q4	$4.15M	Sell	51,199 -134,984	-73%	-$10.3M	0.03%	90
2020 Q3	$8.67M	Buy	+186,183	New	+$10.4M	0.07%	68

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HHLR Advisors's CVAC Position: Q1 2021 in Review

HHLR Advisors sold out of CureVac (CVAC) in Q1 2021, closing a stake of 51,199 shares — an estimated $4.15M sold.

HHLR Advisors first reported a position in CVAC in Q3 2020 and held it in 2 quarters. The position peaked at $8.67M in Q3 2020. 84 funds tracked by Wall St. Rank hold CVAC as of Q1 2021.

HHLR Advisors reported no remaining CureVac position as of Q1 2021 after selling out during the quarter.
HHLR Advisors sold 51,199 CureVac shares in Q1 2021, an estimated $4.15M.
HHLR Advisors first reported a position in CureVac in Q3 2020 and held it in 2 quarters.
HHLR Advisors's CureVac position peaked at $8.67M in Q3 2020.
84 funds tracked by Wall St. Rank held CureVac as of Q1 2021.

Based on HHLR Advisors's 13F filing for Q1 2021, filed 17 May 2021.